BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1795130)

  • 1. Urinary neopterin in malignant lymphoma.
    Piccinini L; Zironi S; Federico M; Pini LA; Luppi G
    Int J Biol Markers; 1991; 6(4):231-6. PubMed ID: 1795130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of urinary neopterin in non-Hodgkin's lymphomas.
    Abate G; Comella P; Marfella A; Santelli G; Nitsch F; Fiore M; Perna M
    Cancer; 1989 Feb; 63(3):484-9. PubMed ID: 2912527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble interleukin-2 receptor and urinary neopterin concentrations in malignant lymphoma.
    Piccinini L; Zironi S; Cenci AM; Campioli D; Federico M; Barbieri F
    Eur J Clin Chem Clin Biochem; 1993 Sep; 31(9):567-74. PubMed ID: 8260527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary neopterin levels in hematologic malignancies.
    Santelli G; Marfella A; Abate G; Comella P; Nitsch F; Perna M
    Tumori; 1986 Apr; 72(2):139-43. PubMed ID: 3705186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of urinary neopterin and pseudouridine in patients with malignant proliferative diseases.
    Motyl T; Traczyk Z; Holska W; Daniewska-Michalska D; Cieśluk S; Kukulska W; Kałuzny Z; Podgurniak M
    Eur J Clin Chem Clin Biochem; 1993 Apr; 31(4):205-9. PubMed ID: 8318566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered urinary excretion of pteridines in neoplastic disease. Determination of biopterin, neopterin, xanthopterin, and pterin.
    Rokos H; Rokos K; Frisius H; Kirstaedter HJ
    Clin Chim Acta; 1980 Aug; 105(2):275-86. PubMed ID: 7398095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of urinary neopterin in a non-Hodgkin's lymphoma patient during chemotherapy and radiotherapy.
    Tomandl J; Palyza V; Tallová J; Drbal J
    J Exp Clin Cancer Res; 2004 Mar; 23(1):157-61. PubMed ID: 15149166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary neopterine in the assessment of lymphoid and myeloid neoplasia, and neopterine levels in haemolytic anaemia and benign monoclonal gammopathy.
    Hausen A; Fuchs D; Grünewald K; Huber H; König K; Wachter H
    Clin Biochem; 1982 Feb; 15(1):34-7. PubMed ID: 7067074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary hydroxyproline excretion in patients with Hodgkin's disease and non-Hodgkin's lymphoma.
    Nehlawi MF; Shaw D; Mitchell PE; Cuschieri A
    Clin Oncol; 1979 Jun; 5(2):109-14. PubMed ID: 466890
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary excretion of pseudouridine and prognosis of patients with malignant lymphoma.
    Rasmuson T; Björk GR
    Acta Oncol; 1995; 34(1):61-7. PubMed ID: 7865238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of urinary neopterin as an immunological parameter in patients with malignant tumors of the genitourinary tract.
    Frick J; Aulitzky W; Fuchs D; Hausen A; Joos H; Reibnegger G; Wachter H
    Urol Int; 1985; 40(3):155-9. PubMed ID: 3874460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary neopterine as marker for haematological neoplasias.
    Hausen A; Fuchs D; Grünewald K; Huber H; König K; Wachter H
    Clin Chim Acta; 1981 Dec; 117(3):297-305. PubMed ID: 7318183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of urinary neopterin levels in patients with hepatocellular carcinoma.
    Kawasaki H; Watanabe H; Yamada S; Watanabe K; Suyama A
    Tohoku J Exp Med; 1988 Aug; 155(4):311-8. PubMed ID: 2852855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal excretion of neopterine and biopterine in patients with malignant melanoma and Hodgkin's disease.
    Zitko M; Andrysek O; Cernovská I; Vasícková M
    Neoplasma; 1986; 33(3):387-91. PubMed ID: 3736723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress of radiation therapy in malignant lymphomas].
    Kaneta K; Nakazawa N; Kawabata K; Hashida J; Kawaguchi T; Yamashita T
    Gan No Rinsho; 1988 Apr; 34(5):555-64. PubMed ID: 3385921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between urinary neopterin excretion and islet cell antibodies in type 1 (insulin-dependent) diabetes.
    Manna R; Salvatore M; Di Leo MA; Scuderi F; Greco AV; Ghirlanda G; Gambassi G
    Diabetes Res; 1991 May; 17(1):33-6. PubMed ID: 1816978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary neopterin and immunological features in patients with Kaposi's sarcoma.
    Santelli G; Melillo G; Marfella A; Napolitano M; D'Alessio V; Satriano RA; Beth-Giraldo E; Giraldo G; Perna M; Castello G
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1391-6. PubMed ID: 3263274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neopterin in patients with choroidal melanoma.
    Gerding H; Cremer-Bartels G; Krause K; Busse H
    Eur J Clin Chem Clin Biochem; 1993 Apr; 31(4):221-4. PubMed ID: 8318569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in Hodgkin's and non-Hodgkin's lymphomas.
    Coiffier B
    Curr Opin Oncol; 1991 Oct; 3(5):843-51. PubMed ID: 1751578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary neopterin excretion in patients with uterine sarcomas.
    Fuith LC; Fuchs D; Hausen A; Hetzel H; Reibnegger G; Werner ER; Wachter H
    Cancer; 1990 Mar; 65(5):1228-31. PubMed ID: 2302670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.